Pivotal Therapeutics announces issuance of U.S. Patent 8,715,648 for its unique 6:1 EPA:DHA formulation

May 07, 2014, 11:39 ET from Pivotal Therapeutics Inc.

SOURCE Pivotal Therapeutics Inc.



RELATED LINKS

www.pivotaltherapeutics.us